Refer a Friend
Do you know someone with agitation associated with Alzheimer's dementia, or a carer who's loved one is showing signs of agitated behavior? They may be eligible to participate in the TRIAD Research Study.
Common behaviors of agitation associated with Alzheimer's dementia may include cursing, screaming, hitting, throwing things, kicking, pacing or wandering, and restlessness.
To qualify for this study, individuals must be 50 to 90 years old, and have symptoms of agitation associated with Alzheimer's dementia. Additional criteria apply.
The TRIAD Research Study is evaluating an investigational drug to determine if it reduces the symptoms of agitation associated with Alzheimer's dementia in participants.
Patients diagnosed with Alzheimer's dementia are known to have memory problems. Less well known is that some patients with Alzheimer's dementia may also have certain behavioral changes called agitation. These behaviors can be very disturbing for patients and their loved ones. Examples of some easily identified agitated behaviors are: restlessness, repeating questions, wandering, pointing fingers, rocking, yelling, screaming, cursing, hitting self or others, kicking, pushing, resisting, throwing objects, and slamming doors. Do any of these behavioral changes describe you or your loved one?
People with Alzheimer's dementia showing signs of agitated behavior may be eligible to enroll in the TRIAD Research Study.READ MORE ABOUT AGITATION
The purpose of this research study is to test an investigational drug (also called the study drug) to determine if it might reduce the symptoms of agitation associated with Alzheimer's dementia, as well as testing its safety and tolerability in participants. At this time, there are no medications approved to treat patients diagnosed with agitation associated with Alzeimer's dementia. By participating in the TRIAD Research Study, you could help to advance future treatment options for this condition.
Additional criteria for eligibility will apply.